CORRESP Filing
VOLITIONRX LTD
Date: Feb. 17, 2026 · CIK: 0000093314 · Accession: 0001477932-26-000865
AI Filing Summary & Sentiment
Reasoning
Letter
vnrx_corresp.htm VOLITIONRX LIMITED 1489 West Warm Springs Road, Suite 110 Henderson, Nevada 89014 February 17, 2026 SUBMITTED VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Doris Stacey Gama Re: VolitionRx Limited’s Acceleration Request Registration Statement on Form S-3 Filed February 9, 2026 File No. 333- 293314 Requested Date : February 19, 2026 Requested Time : 5:00 P.M. Eastern Time Ladies and Gentlemen: Pursuant to Rule 461 of the Securities Act of 1933, as amended, VolitionRx Limited, a Delaware corporation (the “ Company ”), hereby respectfully requests that the Securities and Exchange Commission (the “ Commission ”) takes appropriate action to declare the above-captioned Registration Statement on Form S-3 effective as of the “Requested Date” and “Requested Time” set forth above, or as soon thereafter as practicable. Should the Commission have any questions regarding this acceleration request, please do not hesitate to contact Marc G. Alcser, an attorney with the Company’s outside legal counsel, Stradling Yocca Carlson & Rauth LLP, via telephone at (949) 725-4136 or via email at malcser@stradlinglaw.com . We respectfully request that you contact Mr. Alcser via telephone as soon as the above referenced Registration Statement has been declared effective. Sincerely, VOLITIONRX LIMITED /s/ Cameron Reynolds Cameron Reynolds President and Chief Executive Officer cc: VolitionRx Limited Terig Hughes, Chief Financial Officer Stradling Yocca Carlson & Rauth LLP Marc G. Alcser, Esq.
Show Raw Text
CORRESP 1 filename1.htm vnrx_corresp.htm VOLITIONRX LIMITED 1489 West Warm Springs Road, Suite 110 Henderson, Nevada 89014 February 17, 2026 SUBMITTED VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Doris Stacey Gama Re: VolitionRx Limited’s Acceleration Request Registration Statement on Form S-3 Filed February 9, 2026 File No. 333- 293314 Requested Date : February 19, 2026 Requested Time : 5:00 P.M. Eastern Time Ladies and Gentlemen: Pursuant to Rule 461 of the Securities Act of 1933, as amended, VolitionRx Limited, a Delaware corporation (the “ Company ”), hereby respectfully requests that the Securities and Exchange Commission (the “ Commission ”) takes appropriate action to declare the above-captioned Registration Statement on Form S-3 effective as of the “Requested Date” and “Requested Time” set forth above, or as soon thereafter as practicable. Should the Commission have any questions regarding this acceleration request, please do not hesitate to contact Marc G. Alcser, an attorney with the Company’s outside legal counsel, Stradling Yocca Carlson & Rauth LLP, via telephone at (949) 725-4136 or via email at malcser@stradlinglaw.com . We respectfully request that you contact Mr. Alcser via telephone as soon as the above referenced Registration Statement has been declared effective. Sincerely, VOLITIONRX LIMITED /s/ Cameron Reynolds Cameron Reynolds President and Chief Executive Officer cc: VolitionRx Limited Terig Hughes, Chief Financial Officer Stradling Yocca Carlson & Rauth LLP Marc G. Alcser, Esq.